NEW YORK (GenomeWeb News) – The US Department of Defense has awarded BioFire Diagnostics, formerly called Idaho Technology, a contract for up to $27.4 million.

In an announcement last week, the Defense Logistics Agency of DOD said the award is a modification on the second option year of a previously awarded contract and is a firm fixed-price, sole-source, indefinite delivery and indefinite quantity contract for reagents, extraction, and inhibition kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.